Prolactin suppresses GnRH but not TSH secretion

Hormone Research

Volumn 65, Issue 1, 2006, Pages 31-38

  Page Wilson, G ^a,b   Smith, P C ^a   Welt, C K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Amenorrhea; Gonadotropin releasing hormone; Hyperprolactinemia; Hypothalamus; Menstrual cycle

Indexed keywords

ESTRADIOL; GONADORELIN; INHIBIN A; INHIBIN B; LUTEINIZING HORMONE; PROLACTIN; RECOMBINANT HUMAN PROLACTIN; THYROTROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; GONADORELIN RELEASE; HUMAN; HYPERPROLACTINEMIA; HYPOTHESIS; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE;

ADULT; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPERPROLACTINEMIA; INHIBINS; LUTEINIZING HORMONE; MENSTRUAL CYCLE; PROGESTERONE; PROLACTIN; RECOMBINANT PROTEINS; THYROTROPIN;

EID: 31744438951     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090377     Document Type: Article

References (60)

1. Hokfelt T, Fuxe K: Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons. Neuroendocrinology 1972;9:100-122.
2. Advis JP, Hall TR, Hodson CA, Mueller GP, Meites J: Temporal relationship and role of dopamine in 'short-loop' feedback of prolactin. Proc Soc Exp Biol Med 1977;155:567-570.
3. Gudelsky GA, Porter JC: Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration. Endocrinology 1980;106:526-529.
4. Selmanoff M: Rapid effects of hyperprolactinemia on basal prolactin secretion and dopamine turnover in the medial and lateral median eminence. Endocrinology 1985;116:1943-1952.
5. Bybee DE, Nakawatase C, Szabo M, Frohman LA: Inhibitory feedback effects of prolactin on its secretion involve central nervous system dopaminergic mediation. Neuroendocrinology 1983;36:27-32.
6. Glasier A, McNeilly AS, Howie PW: Pulsatile secretion of LH in relation to the resumption of ovarian activity post partum. Clin Endocrinol (Oxf) 1984;20:415-426.
7. Moult PJ, Rees LH, Besser GM: Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea and the response to bromocriptine therapy. Clin Endocrinol (Oxf) 1982;16:153-162.
8. Bohnet HG, Dahlen HG, Wuttke W, Schneider HPG: Hyperprolactinemic anovulatory syndrome. J Clin Endocrinol Metab 1976;42:132-143.
9. Ordog T, Chen MD, O'Byrne KT, Goldsmith JR, Connaughton MA, Hotchkiss J, Knobil E: On the mechanism of lactational anovulation in the rhesus monkey. Am J Physiol 1998;274:E665-E676.
10. Smith MS, Grove KL: Integration of the regulation of reproductive function and energy balance: lactation as a model. Front Neuroendocrinol 2002;23:225-256.
11. Kremer JA, Borm G, Schellekens LA, Thomas CM, Rolland R: Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone. J Clin Endocrinol Metab 1991;72:294-300.
12. Scanlon MF, Rodriguez-Arnao MD, McGregor AM, Weightman D, Lewis M, Cook DB, Gomez-Pan A, Hall R: Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Clin Endocrinol (Oxf) 1981;14:133-143.
13. Holdaway IM, Evans MC, Sheehan A, Ibbertson HK: Low thyroxine levels in some hyperprolactinemic patients due to dopaminergic suppression of thyrotropin. J Clin Endocrinol Metab 1984;59:608-613.
14. Seki K, Kato K: Increased thyroid-stimulating hormone response to thyrotropin-releasing hormone in hyperprolactinemic women. J Clin Endocrinol Metab 1985;61:1138-1141.
15. Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC: Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine. J Clin Endocrinol Metab 1984;59:941-948.
16. Buckman MT, Peake GT, Srivastava L: Patterns of spontaneous LH release in normo- and hyperprolactinaemic women. Acta Endocrinol (Copenh) 1981;97:305-310.
17. Klibanski A, Beitins IZ, Merriam GR, McArthur JW, Zervas NT, Ridgway EC: Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy. J Clin Endocrinol Metab 1984;58:1141-1147.
18. Rossmanith WG, Mortola JF, Yen SS: Effects of acute hyperprolactinemia on LH pulsatile secretion in hypogonadal and early follicular phase women. Life Sci 1988;43:247-253.
19. Quigley ME, Judd SJ, Gilliland GB, Yen SS: Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation. J Clin Endocrinol Metab 1979;48:718-720.
20. Kordon C, Drouva SV, Martinez de la Escalara G, Weiner RI (1994) Role of classic and peptide neuromediators in the neuroendocrine regulation of luteinizing hormone and prolactin; in Knobil E, Neill JD (eds): The Physiology of Reproduction. New York, Raven Press, pp 1621-1682.
21. Park SK, Strouse DA, Selmanoff M: Prolactin-and testosterone-induced inhibition of LH secretion after orchidectomy: role of catecholaminergic neurones terminating in the diagonal band of Broca, medial preoptic nucleus and median eminence. J Endocrinol 1996;148:291-301.
22. Gallo RV: Further studies on dopamine-induced suppression of pulsatile LH release in ovariectomized rats. Neuroendocrinology 1981;32:187-192.
23. Ho KY, Smythe GA, Lazarus L: Dopaminergic control of gonadotrophin secretion in normal women and in patients with pathological hyperprolactinaemia. Clin Endocrinol (Oxf) 1984;20:53-63.
24. Kaptein EM, Kletzky OA, Spencer CA, Nicoloff JT: Effects of prolonged dopamine infusion on anterior pituitary function in normal males. J Clin Endocrinol Metab 1980;51:488-491.
25. Quigley ME, Yen SS: Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma. Am J Obstet Gynecol 1980;137:653-655.
26. Massara F, Camanni F, Martra M, Dolfin GC, Muller EE, Molinatti GM: Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia. Clin Endocrinol (Oxf) 1983;18:103-110.
27. Ghigo E, Goffi S, Molinatti GM, Camanni F, Massara F: Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade. Clin Endocrinol (Oxf) 1985;23:155-160.
28. Besses GS, Burrow GN, Spaulding SW, Donabedian RK: Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. J Clin Endocrinol Metab 1975;41:985-988.
29. Sowers JR, Catania RA, Hershman JM: Evidence for dopaminergic control of circadian variations in thyrotropin secretion. J Clin Endocrinol Metab 1982;54:673-675.
30. Molitch ME, Rebar RW, Barsano CP: Effect of human prolactin administration on gonadotropin and thyrotropin secretion in normal men. J Endocrinol Invest 1993;16:559-563.
31. Filicori M, Flamigni C, Crowley WF Jr: The critical role of blood sampling frequency in the estimation of episodic luteinizing hormone secretion in normal women; in Crowley WF Jr, Hofler JG (eds): The Episodic Secretion of Hormones. New York, Churchill-Livingstone, 1987, pp 5-13.
32. Aono T, Shioji T, Shoda T, Kurachi K: The initiation of human lactation and prolactin response to suckling. J Clin Endocrinol Metab 1977;44:1101-1106.
33. Johnston JM, Amico JA: A prospective longitudinal study of the release of oxytocin and prolactin in response to infant suckling in long term lactation. J Clin Endocrinol Metab 1986;62:653-657.
34. Battin DA, Marrs RP, Fleiss PM, Mishell DR: Effect of suckling on serum prolactin, luteinizing hormone, follicle-stimulating hormone, and estradiol during prolonged lactation. Obstet Gynecol 1985;65:785-788.
35. Noel GL, Suh HK, Frantz AG: Prolactin release during nursing and breast stimulation in postpartum and nonpostpartum subjects. J Clin Endocrinol Metab 1973;38:413-423.
36. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J: Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 1997;82:2102-2107.
37. Price AE, Logvinenko KB, Higgins EA, Cole ES, Richards SM: Studies on the microheterogeneity and in vitro activity of glycosylated and nonglycosylated recombinant human prolactin separated using a novel purification process. Endocrinology 1995;136:4827-4833.
38. Hayes FJ, McNicholl DJ, Schoenfeld D, Marsh EE, Hall JE: Free α-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies. J Clin Endocrinol Metab 1999;84:1028-1036.
39. Veldhuis JD, Johnson ML: Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol 1986;250:E486-E493.
40. Sowa M, Tsuji K, Nakano R: Effects of sulpiride-induced hyperprolactinemia on human ovarian follicles during the late follicular phase. Fertil Steril 1986;46:1032-1036.
41. Kauppila A, Kirkinen P, Orava M, Vihko R: Effects of metoclopramide- induced hyperprolactinemia during early follicular development on human ovarian function. J Clin Endocrinol Metab 1984;59:875-881.
42. Welt CK, Adams JM, Sluss PM, Hall JE: Inhibin A and inhibin B responses to gonadotropin withdrawal depends on stage of follicle development. J Clin Endocrinol Metab 1999;84:2163-2169.
43. Welt CK, Pagan YL, Smith PC, Rado KB, Hall JE: Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab 2003;88:1766-1771.
44. Welt CK, McNicholl D, Taylor AE, Hall JE: Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999;84:105-111.
45. Mangat HK, McCann SM: Acute inhibition of PRL and TSH secretion after intraventricular injection of PRL in ovariectomized rats. Am J Physiol 1983;244:E31-E36.
46. Cohen-Becker IR, Selmanoff M, Wise PM: Hyperprolactinemia alters the frequency and amplitude of pulsatile luteinizing hormone secretion in the ovariectomized rat. Neuroendocrinology 1986;42:328-333.
47. Clarke IJ, Cummins JT: The temporal relationship between gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized ewes. Endocrinology 1982;111:1737-1739.
48. Levine JE, Pau KF, Ramirez VD, Jackson GL: Simultaneous measurement of luteinizing hormone-releasing hormone and luteinizing hormone release in the unanesthetized, ovariectomized sheep. Endocrinology 1982;111:1449-1455.
49. Milenkovic L, D'Angelo G, Kelly PA, Weiner RI: Inhibition of gonadotropin hormone-releasing hormone release by prolactin from GT1 neuronal cell lines through prolactin receptors. Proc Natl Acad Sci USA 1994;91:1244-1247.
50. Park SK, Selmanoff M: Hyperprolactinemia suppresses the luteinizing hormone responses to N-methyl-D-aspartate, epinephrine, and neuropeptide-Y in male rats. Endocrinology 1993;133:2091-2097.
51. Cook CB, Nippoldt TB, Kletter GB, Kelch RP, Marshall JC: Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia. J Clin Endocrinol Metab 1991;73:1099-1105.
52. Filicori M, Santoro N, Merriam GR, Crowley WF Jr: Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 1986;62:1136-1144.
53. Ylikorkala O, Kauppila A: The effects on the ovulatory cycle of metoclopramide-induced increased prolactin levels during follicular development. Fertil Steril 1981;35:588-589.
54. Oseko F, Morikawa K, Motohashi T, Aso T: Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women. Obstet Gynecol 1988;72:267-271.
55. Dunaif AE, Zimmerman EA, Friesen HG, Frantz AG: Intracellular localization of prolactin receptor and prolactin in the rat ovary by immunocytochemistry. Endocrinology 1982;110:1465-1471.
56. Oxberry BA, Greenwald GS: An autoradiographic study of the binding of 125 I-labeled follicle-stimulating hormone, human chorionic gonadotropin and prolactin to the hamster ovary throughout the estrous cycle. Biol Reprod 1982;27:505-516.
57. Richards SM, Garman RD, Keyes L, Kavanagh B, McPherson JM: Prolactin is an antagonist of TGF-beta activity and promotes proliferation of murine B cell hybridomas. Cell Immunol 1998;184:85-91.
58. Demura R, Ono M, Demura H, Shizume K, Oouchi H: Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17β-estradiol in the human ovary. J Clin Endocrinol Metab 1982;54:1246-1250.
59. McNatty KP, Sawers RS, McNeilly AS: A possible role for prolactin in control of steroid secretion by the human Graafian follicle. Nature 1974;250:653-655.
60. Polan ML, Laufer N, Dlugi AM, Tarlatzis BC, Haseltine FP, DeCherney AH, Behrman HR: Human chorionic gonadotropin and prolactin modulation of early luteal function and luteinizing hormone receptor-binding activity in cultured human granulosa-luteal cells. J Clin Endocrinol Metab 1984;59:773-779.